Pharmacovigilance
Prescription, Nonprescription and Orphan Drugs
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drug Products: Biologics, Biosimilars and Interchangeables
FDA Approved Drugs: Changes to Approved Drugs
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Updated: Jul 14, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland 0754, New Zealand. dru@adis.com.
抗素-17A抗体Vunakizumab于2024年8月获得中国批准,用于中度至重度的斑块性牛皮. 这标志着治疗IL-17介导的自身免疫性疾病的重要里程碑.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: